Huntsman Carole, Chief Commercial Officer at Madrigal Pharmaceuticals ($MDGL), sold about $1.7 million in company shares across 14 open market transactions over the past year. Her most recent sale occurred on March 6, 2026. These sales rank her 3,791st among 11,678 insiders in our database by total value sold, below the average of $8.6 million per insider and 6.4 transactions. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | A | Stock Option (Right to Buy) | 4986 | $0.00 | 4,986.0000 | 22,939,969 | 9999.99% | 0.02% |
| March 6, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 419 | $431.94 | 12,692.0000 | 22,939,969 | 3.20% | 0.00% |
| March 4, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | A | Common Stock | 3989 | $0.00 | 13,111.0000 | 22,939,969 | 43.73% | 0.02% |
| Jan. 26, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 340 | $492.42 | 9,692.0000 | 22,711,420 | 3.39% | 0.00% |
| Jan. 26, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 570 | $494.59 | 9,122.0000 | 22,711,420 | 5.88% | 0.00% |
| Nov. 21, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 894 | $550.97 | 11,096.0000 | 22,711,420 | 7.46% | 0.00% |
| Nov. 21, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 144 | $547.27 | 10,952.0000 | 22,711,420 | 1.30% | 0.00% |
| Nov. 21, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 120 | $548.71 | 10,832.0000 | 22,711,420 | 1.10% | 0.00% |
| Nov. 21, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 40 | $549.34 | 10,792.0000 | 22,711,420 | 0.37% | 0.00% |
| Nov. 21, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 200 | $552.38 | 10,592.0000 | 22,711,420 | 1.85% | 0.00% |
| Nov. 21, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 40 | $553.23 | 10,552.0000 | 22,711,420 | 0.38% | 0.00% |
| Nov. 21, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 120 | $556.04 | 10,432.0000 | 22,711,420 | 1.14% | 0.00% |
| Nov. 21, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 200 | $559.60 | 10,232.0000 | 22,711,420 | 1.92% | 0.00% |
| Nov. 21, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 80 | $560.62 | 10,152.0000 | 22,711,420 | 0.78% | 0.00% |
| Nov. 21, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 40 | $563.21 | 10,112.0000 | 22,711,420 | 0.39% | 0.00% |
| Nov. 21, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 80 | $564.57 | 10,032.0000 | 22,711,420 | 0.79% | 0.00% |
| March 5, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | A | Stock Option (Right to Buy) | 5703 | $0.00 | 5,703.0000 | 22,080,246 | 9999.99% | 0.03% |
| March 5, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | A | Common Stock | 3386 | $0.00 | 11,990.0000 | 22,080,246 | 39.35% | 0.02% |
| March 3, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 300 | $320.21 | 9,867.0000 | 22,080,246 | 2.95% | 0.00% |
| March 3, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 200 | $314.74 | 10,167.0000 | 22,080,246 | 1.93% | 0.00% |
| March 3, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 71 | $313.08 | 10,367.0000 | 22,080,246 | 0.68% | 0.00% |
| March 3, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 200 | $324.59 | 9,467.0000 | 22,080,246 | 2.07% | 0.00% |
| March 3, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 100 | $326.34 | 9,367.0000 | 22,080,246 | 1.06% | 0.00% |
| March 3, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 100 | $329.64 | 9,167.0000 | 22,080,246 | 1.08% | 0.00% |
| March 3, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 563 | $335.00 | 8,604.0000 | 22,080,246 | 6.14% | 0.00% |
| March 3, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 100 | $327.49 | 9,267.0000 | 22,080,246 | 1.07% | 0.00% |
| March 3, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 200 | $323.65 | 9,667.0000 | 22,080,246 | 2.03% | 0.00% |
| Jan. 24, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 347 | $335.24 | 10,438.0000 | 0 | 3.22% | 0.00% |
| Nov. 21, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | S | Common Stock | 688 | $316.92 | 10,785.0000 | 0 | 6.00% | 0.00% |
| Jan. 23, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | A | Common Stock | 3639 | $0.00 | 11,473.0000 | 0 | 46.45% | 0.00% |
| Jan. 23, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | A | Stock Option (Right to Buy) | 5483 | $0.00 | 5,483.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Huntsman Carole | Chief Commercial Officer | A | Market Stock Unit | 3639 | $0.00 | 3,639.0000 | 0 | 9999.99% | 0.00% |